Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698986 | SCV000223636 | uncertain significance | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function; Variants in candidate genes are classified as variants of uncertain significance in accordance with ACMG guidelines (PMID: 25741868) |
Ambry Genetics | RCV000619472 | SCV000735544 | likely benign | Cardiovascular phenotype | 2024-08-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001216410 | SCV001388207 | uncertain significance | Long QT syndrome 10 | 2025-02-02 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 6 of the SCN4B protein (p.Asp6Glu). This variant is present in population databases (rs149979176, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with SCN4B-related conditions. ClinVar contains an entry for this variant (Variation ID: 190889). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Center for Genomics, |
RCV001216410 | SCV003920436 | uncertain significance | Long QT syndrome 10 | criteria provided, single submitter | clinical testing | SCN4B NM_174934.3 exon 1 p.Asp6Glu (c.18C>A): This variant has not been reported in the literature but is present in 0.02% (30/124990) of European alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/11-118023371-G-T). This variant is present in ClinVar (Variation ID:190889). Evolutionary conservation and computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005406881 | SCV006072337 | likely benign | not specified | 2025-03-07 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001698986 | SCV001922696 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001698986 | SCV001927453 | likely benign | not provided | no assertion criteria provided | clinical testing |